PMDA

Mumbai, India, and Naples, Florida, USA, September 4, 2026 Lupin Limited has received U.S. Food and Drug Administration (FDA)...

Incheon, South Korea, September 3, 2026 Samsung Bioepis has announced that its ustekinumab biosimilar has received marketing approval in...

AUSTIN, Texas, August 5, 2026 Natera, Inc. has submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)...

ROCKVILLE, Maryland, July 4, 2026 Immunomic Therapeutics Inc. (ITI), a clinical-stage biotechnology company and subsidiary of HLB, has announced...

INCHEON, South Korea, May 20, 2026 Samsung Bioepis has announced the official launch of Ustekinumab BS 45 mg Syringe...

TOKYO & STOCKHOLM — November 28, 2025. Eisai, in partnership with BioArctic, has submitted a New Drug Application (NDA)...